EMERYVILLE, Calif., March 1, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that Kelly MacDonald, Chief Financial Officer, will participate in a fireside...
News Ticker
- [ March 29, 2023 ] Layoffs hit private gene therapy startups, migraine biotech Satsuma as industry squeeze doesn’t let up News
- [ March 29, 2023 ] SIMPLETHERAPY® ANNOUNCES ACQUISITION OF PHYSMETRICS AND HALCYON BEHAVIORAL News
- [ March 29, 2023 ] SimX Awarded U.S. Air Force Contract to Develop VR Medical Support Training Simulations for Aeromedical Evacuation and Critical Care Air Transport Training News
- [ March 29, 2023 ] Assay Development, Research Associate – Adela, Inc. – Foster City, CA San Francisco Biotech Jobs
- [ March 29, 2023 ] Biomea goes for $125M offering after early diabetes data nearly doubled stock price News
Copyright © 2022 Biotech Networks, LLC
